Clinical trials
Stroke trials in Austria
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
81 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2002 | 1 |
| 2003 | 3 |
| 2004 | 1 |
| 2005 | 6 |
| 2006 | 4 |
| 2007 | 3 |
| 2008 | 3 |
| 2009 | 5 |
| 2010 | 4 |
| 2011 | 5 |
| 2012 | 3 |
| 2013 | 2 |
| 2014 | 8 |
| 2015 | 3 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 3 |
| 2019 | 4 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 3 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 56 |
| Terminated | 10 |
| Recruiting | 7 |
| Unknown status | 4 |
| Active, not recruiting | 3 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Boehringer Ingelheim | 6 |
| Bayer | 4 |
| Novartis Pharmaceuticals | 4 |
| Insel Gruppe AG, University Hospital Bern | 3 |
| Astellas Pharma Inc | 2 |
| AstraZeneca | 2 |
| CENTOGENE GmbH Rostock | 2 |
| Columbia University | 2 |
| IRCCS San Camillo, Venezia, Italy | 2 |
| Karl Landsteiner University of Health Sciences | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Stroke | 81 |
| Ischemic Stroke | 16 |
| Atrial Fibrillation | 11 |
| Cardiovascular Diseases | 8 |
| Myocardial Infarction | 7 |
| Ischemia | 6 |
| Ischemic Attack, Transient | 6 |
| Atherosclerosis | 4 |
| Embolism | 4 |
| Thrombosis | 4 |
Trials
Showing 51 to 75 of 81. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.